LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 45.61 | 770.25 | 4166 | 5813 | 0.7167 | 0.7841 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 47.83 | 770.25 | 5170 | 6223 | 0.8307 | 0.8807 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 47.83 | 770.25 | 4475 | 6223 | 0.7191 | 0.7927 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 50.05 | 770.25 | 5483 | 6629 | 0.8271 | 0.8814 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 50.05 | 770.25 | 4693 | 6629 | 0.7079 | 0.7895 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 52.27 | 770.25 | 5758 | 7058 | 0.8157 | 0.8765 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 52.27 | 770.25 | 5018 | 7058 | 0.7109 | 0.7975 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 54.49 | 770.25 | 6215 | 7555 | 0.8226 | 0.8849 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 54.49 | 770.25 | 5314 | 7555 | 0.7033 | 0.7974 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 56.71 | 770.25 | 6565 | 8001 | 0.8205 | 0.8862 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 56.71 | 770.25 | 5666 | 8001 | 0.7081 | 0.8057 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 58.94 | 770.25 | 6922 | 8444 | 0.8197 | 0.8882 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 58.94 | 770.25 | 5986 | 8444 | 0.7089 | 0.8104 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 61.16 | 770.25 | 7403 | 8892 | 0.8326 | 0.8988 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 61.16 | 770.25 | 6379 | 8892 | 0.7174 | 0.8204 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 63.39 | 770.25 | 7766 | 9326 | 0.8327 | 0.9008 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 63.39 | 770.25 | 6693 | 9326 | 0.7177 | 0.8238 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 65.61 | 770.25 | 8147 | 9736 | 0.8368 | 0.9050 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 65.61 | 770.25 | 7071 | 9736 | 0.7263 | 0.8327 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 67.83 | 770.25 | 8376 | 10078 | 0.8311 | 0.9027 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 67.83 | 770.25 | 7274 | 10078 | 0.7217 | 0.8317 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 70.05 | 770.25 | 8755 | 10413 | 0.8407 | 0.9097 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 70.05 | 770.25 | 7516 | 10413 | 0.7218 | 0.8337 | MN20160304_L02 | N06 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 72.27 | 770.25 | 9169 | 10730 | 0.8545 | 0.9189 | MN20160304_L02 | K19 |
MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 72.27 | 770.25 | 7793 | 10730 | 0.7262 | 0.8385 | MN20160304_L02 | N06 |